Healios KK
TSE:4593

Watchlist Manager
Healios KK Logo
Healios KK
TSE:4593
Watchlist
Price: 328 JPY 5.13%
Market Cap: 37.9B JPY

Wall Street
Price Targets

Price Targets Summary
Healios KK

Wall Street analysts forecast Healios KK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Healios KK is 657.9 JPY with a low forecast of 515.1 JPY and a high forecast of 756 JPY.

Lowest
Price Target
515.1 JPY
57% Upside
Average
Price Target
657.9 JPY
101% Upside
Highest
Price Target
756 JPY
130% Upside
Healios KK Competitors:
Price Targets
688105
Nanjing Vazyme Biotech Co Ltd
44% Upside
NRIX
Nurix Therapeutics Inc
47% Upside
CRNX
Crinetics Pharmaceuticals Inc
68% Upside
VITR
Vitrolife AB
47% Upside
ALCLS
Cellectis SA
93% Upside
IMDX
Insight Molecular Diagnostics Inc
40% Upside
SOBI
Swedish Orphan Biovitrum AB (publ)
13% Upside
VLA
Valneva SE
102% Upside

Revenue
Forecast

Revenue Estimate
Healios KK

For the last 10 years the compound annual growth rate for Healios KK's revenue is 7%. The projected CAGR for the next 3 years is 106%.

7%
Past Growth
106%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Healios KK

Operating Income forecast
is not available for
Healios KK

Net Income
Forecast

Net Income Estimate
Healios KK

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-36%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Healios KK's stock price target?
Price Target
657.9 JPY

According to Wall Street analysts, the average 1-year price target for Healios KK is 657.9 JPY with a low forecast of 515.1 JPY and a high forecast of 756 JPY.

What is Healios KK's Revenue forecast?
Projected CAGR
106%

For the last 10 years the compound annual growth rate for Healios KK's revenue is 7%. The projected CAGR for the next 3 years is 106%.

Back to Top